Publicaciones en colaboración con investigadores/as de Hospital del Mar (20)

2024

  1. A Randomized Trial on Hemodynamic Optimization of Cerebral Perfusion after Successful Endovascular Therapy in Patients with Acute Ischemic Stroke (HOPE)

    Cerebrovascular Diseases

  2. A multitrait genetic study of hemostatic factors and hemorrhagic transformation after stroke treatment

    Journal of Thrombosis and Haemostasis, Vol. 22, Núm. 4, pp. 936-950

2022

  1. Dyslipidemias and stroke prevention: recommendations of the Study Group of Cerebrovascular Diseases of the Spanish Society of Neurology

    Neurologia, Vol. 37, Núm. 1, pp. 61-72

2021

  1. Recommendations of the Spanish Society of Neurology for the prevention of stroke. Interventions on lifestyle and air pollution

    Neurologia, Vol. 36, Núm. 5, pp. 377-387

  2. Rp11-362k2.2:Rp11-767i20.1 genetic variation is associated with post-reperfusion therapy parenchymal hematoma. a gwas meta-analysis

    Journal of Clinical Medicine, Vol. 10, Núm. 14

  3. Single nucleotide variations in ZBTB46 are associated with post-thrombolytic parenchymal haematoma

    Brain, Vol. 144, Núm. 8, pp. 2416-2426

  4. Stroke prevention in patients with arterial hypertension: Recommendations of the Spanish Society of Neurology's Stroke Study Group

    Neurologia, Vol. 36, Núm. 6, pp. 462-471

  5. Stroke prevention in patients with type 2 diabetes or prediabetes. Recommendations from the Cerebrovascular Diseases Study Group, Spanish Society of Neurology

    Neurologia, Vol. 36, Núm. 4, pp. 305-323

2019

  1. PATJ Low Frequency Variants Are Associated with Worse Ischemic Stroke Functional Outcome: A Genome-Wide Meta-Analysis

    Circulation Research, Vol. 124, Núm. 1, pp. 114-120

2017

  1. Frequency and outcome of total anterior circulation strokes without intracranial large-vessel occlusion

    European Journal of Neurology, Vol. 24, Núm. 1, pp. 11-17

  2. Geographic dissemination of endovascular stroke thrombectomy in Catalonia within the 2011–2015 period

    European Stroke Journal, Vol. 2, Núm. 2, pp. 163-170

2016

  1. Access to Endovascular Treatment in Remote Areas: Analysis of the Reperfusion Treatment Registry of Catalonia

    Stroke, Vol. 47, Núm. 5, pp. 1381-1384

  2. Aplicabilidad del índice SPAN-100 en una cohorte prospectiva y contemporánea de pacientes tratados con rtPA por vía intravenosa en Cataluña

    Neurologia, Vol. 31, Núm. 9, pp. 592-598

2014

  1. Clinical management guidelines for subarachnoid haemorrhage. Diagnosis and treatment

    Neurologia

  2. Functional outcome after primary endovascular therapy or IV thrombolysis alone for stroke. An observational, comparative effectiveness study

    Cerebrovascular Diseases, Vol. 38, Núm. 5, pp. 328-336

  3. Outcomes of a contemporary cohort of 536 consecutive patients with acute ischemic stroke treated with endovascular therapy

    Stroke, Vol. 45, Núm. 4, pp. 1046-1052

2013

  1. Hemorrhagic risk of emergent endovascular treatment plus stenting in patients with acute ischemic stroke

    Journal of Stroke and Cerebrovascular Diseases, Vol. 22, Núm. 8, pp. 1326-1331

2008

  1. Influence of antiplatelet pre-treatment on the risk of symptomatic intracranial haemorrhage after intravenous thrombolysis

    Cerebrovascular Diseases, Vol. 26, Núm. 2, pp. 126-133

2007

  1. Frequency and predictors of symptomatic intracerebral hemorrhage in patients with ischemic stroke treated with recombinant tissue plasminogen activator outside clinical trials

    Cerebrovascular Diseases, Vol. 23, Núm. 2-3, pp. 85-90

2006

  1. Aspirin or anticoagulants in stenosis of the middle cerebral artery: A randomized trial

    Cerebrovascular Diseases, Vol. 22, Núm. 2-3, pp. 162-169